
Photo by CDC
The New Coronavirus and the Future of BCG
Between 1921 and the mid-1970s, Bacillus Calmette-Guerin (BCG) was identified and studied exclusively as a vaccine to prevent tuberculosis and leprosy (infections by Mycobacterium tuberculosis and Mycobacterium leprae). Let us recall that BCG contains a weakened strain of Mycobacterium bovis.